Helicobacter pylori Infection and Oesophageal Cancer Risk: Association Studies via Evidence-based Meta-analyses

Clinical Oncology

Volumn 20, Issue 10, 2008, Pages 757-762

  Zhuo, Xianlu ^a   Zhang, Yao ^a   Wang, Yan ^a   Zhuo, Wenlei ^a   Zhu, Yi ^b   Zhang, Xueyuan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Helicobacter pylori; meta analysis; oesophageal adenocarcinoma; oesophageal squamous cell carcinoma; risk

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; EVIDENCE BASED MEDICINE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; DATABASES, FACTUAL; ESOPHAGEAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RISK; RISK FACTORS;

EID: 55249084629     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.07.005     Document Type: Article

References (29)

1. Khanzode S.S., Khanzode S.D., and Dakhale G.N. Serum and plasma concentration of oxidant and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. Cancer Lett 195 (2003) 27-31
2. Arkkila P.E., Kokkola A., Seppala K., et al. Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics. Scand J Gastroenterol 42 (2007) 695-701
3. Li X.B., Ge Z.Z., Chen X.Y., et al. Duodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis. Braz J Med Biol Res 40 (2007) 897-902
4. Wang C., Yuan Y., and Hunt R.H. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 102 (2007) 1789-1798
5. Bourke B. Will treatment of Helicobacter pylori infection in childhood alter the risk of developing gastric cancer?. Can J Gastroenterol 19 (2005) 409-411
6. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. Helicobacter pylori Schistosomes, liver flukes and Helicobacter pylori: views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994), IARC, Lyon 177-240
7. Treiber G., Wittig J., Ammon S., et al. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). Arch Intern Med 162 (2002) 153-160
8. Roche N., Ilver D., Angstrom J., et al. Human gastric glycosphingolipids recognized by Helicobacter pylori vacuolating cytotoxin VacA. Microbes Infect 9 (2007) 605-614
9. Igarashi M., Kitada Y., Yoshiyama H., et al. Ammonia as an accelerator of tumor necrosis factor alpha-induced apoptosis of gastric epithelial cells in Helicobacter pylori infection. Infect Immun 69 (2001) 816-821
10. Kitadai Y., Sasaki A., Ito M., et al. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Commun 311 (2003) 809-814
11. Yokoyama A., Yokoyama T., Omori T., et al. Helicobacter pylori, chronic atrophic gastritis, inactive aldehyde dehydrogenase-2, macrocytosis and multiple upper aerodigestive tract cancers and the risk for gastric cancer in alcoholic Japanese men. J Gastroenterol Hepatol 22 (2007) 210-217
12. Kamangar F., Qiao Y.L., Schiller J.T., et al. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer 119 (2006) 579-584
13. Rosenthal R. The 'file drawer problem' and tolerance for null results. Psychol Bull 86 (1979) 638-641
14. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J 315 (1997) 629-634
15. Chow W.H., Blaser M.J., Blot W.J., et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 58 (1998) 588-590
16. Vicari J.J., Peek R.M., Falk G.W., et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 115 (1998) 50-57
17. Grimley C.E., Holder R.L., Loft D.E., et al. Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol 11 (1999) 503-509
18. Vieth M., Masoud B., Meining A., et al. Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia?. Digestion 62 (2000) 225-231
19. Weston A.P., Badr A.S., Topalovski M., et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 95 (2000) 387-394
20. Wu A.H., Crabtree J.E., Bernstein L., et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 103 (2003) 815-821
21. de Martel C., Llosa A.E., Farr S.M., et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis 191 (2005) 761-767
22. Henrik Simán J., Forsgren A., Berglund G., et al. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter 6 (2001) 310-316
23. Wu D.C., Wu I.C., Lee J.M., et al. Helicobacter pylori infection: a protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenterol 100 (2005) 588-593
24. Kamangar F., Qiao Y.L., Blaser M.J., et al. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 96 (2007) 172-176
25. El-Omar E.M., Rabkin C.S., Gammon M.D., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124 (2003) 1193-1201
26. Ye W., Held M., Lagergren J., et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 96 (2004) 388-396
27. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. Br Med J 327 (2003) 557-560
28. Koike T., Ohara S., Inomata Y., et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan. Inflammopharmacology 15 (2007) 61-64
29. Shahabi S., Rasmi Y., Jazani N.H., et al. Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism. Immunol Cell Biol 86 (2008) 175-178